Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
26 hedge funds and large institutions have $11.6M invested in Marrone Bio Innovations, Inc. in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 9 closing their positions.
19% less funds holding
Funds holding: 32 → 26 (-6)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
50% less capital invested
Capital invested by funds: $23.2M → $11.6M (-$11.6M)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$215K |
| 2 |
EAM
Evanson Asset Management
Carmel,
California
|
+$47.1K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.92K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.28K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.43K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
-$328K |
| 2 |
AIG
American International Group
New York
|
-$151K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$139K |
| 4 |
Millennium Management
New York
|
-$121K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$95.5K |
MBII Hedge Fund Activity: Q4 2015 in Review
26 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q4 2015, worth a combined $11.6M — down 50% from $23.2M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of MBII and 4 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 5 added.
The largest buyer was Bridgeway Capital Management, adding an estimated $215K. The largest seller was Senvest Management, cutting an estimated $328K.
- 26 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q4 2015, down from 32 in Q3 2015.
- Funds reported $11.6M of Marrone Bio Innovations, Inc. stock for Q4 2015, down 50% quarter-over-quarter.
- 4 funds opened new Marrone Bio Innovations, Inc. positions in Q4 2015 and 9 closed out, a net change of -5 holders.
- The largest Marrone Bio Innovations, Inc. buyer in Q4 2015 was Bridgeway Capital Management, an estimated $215K added.
- The largest Marrone Bio Innovations, Inc. seller in Q4 2015 was Senvest Management, an estimated $328K sold.
Based on aggregated 13F filings for Q4 2015.